Bogaerts, Pierre
Oueslati, Saoussen
Meunier, Danièle http://orcid.org/0000-0003-4678-8094
Nonhoff, Claire
Yunus, Sami
Massart, Marion
Denis, Olivier
Woodford, Neil
Hopkins, Katie L.
Naas, Thierry
Dortet, Laurent
Huang, Te-Din
Glupczynski, Youri
Article History
Received: 27 March 2017
Accepted: 30 May 2017
First Online: 30 August 2017
Competing Interests
: PHE’s AMRHAI Reference Unit (Daniele Meunier, Katie L Hopkins and Neil Woodford) has received financial support for conference attendance, lectures, research projects or contracted evaluations from numerous sources, including: Accelerate Diagnostics, Achaogen Inc, Allecra Therapeutics, Amplex, AstraZeneca UK Ltd, Basilea Pharmaceutica, Becton Dickinson Diagnostics, bioMérieux, Bio-Rad Laboratories, The BSAC, Cepheid, Check-Points B.V., Cubist Pharmaceuticals, Department of Health, Enigma Diagnostics, Food Standards Agency, GlaxoSmithKline Services Ltd, Henry Stewart Talks, IHMA Ltd, Kalidex Pharmaceuticals, Melinta Therapeutics, Merck Sharpe & Dohme Corp, Meiji Seika Pharmo Co., Ltd, Mobidiag, Momentum Biosciences Ltd, Nordic Pharma Ltd, Norgine Pharmaceuticals, Rempex Pharmaceuticals Ltd, Roche, Rokitan Ltd, Smith & Nephew UK Ltd, Trius Therapeutics, VenatoRx Pharmaceuticals and Wockhardt Ltd.